You are here: Industry Insights > Biopharma

News List

Rentschler Biopharma Takes on New Projects at Milford, MA Facility contractpharma
September 05, 2019
The site will support both clinical and commercial manufacturing programs .
Prestige BioPharma Releases Positive Results from Phase I Study of HD204, Biosimilar Candidate to Bevacizumab b3cnewswire
July 09, 2019
Prestige BioPharma Releases Positive Results from Phase I Study of HD204, Biosimilar Candidate to Bevacizumab.
Jazz targets docs, consumers with branded Sunosi campaigns fiercepharma
July 09, 2019
Jazz Pharmaceuticals started prepping the ground last year for its new sleep drug launch, and now it's official: The biopharma's Sunosi is rolling out this week with branded doctor advertising, a stepped-up sales force and digital direct-to-consumer pitch
Target Health and dMed Biopharmaceuticals Join Forces to Help Western and Chinese Biopharma and Device Companies En-CPhI.cn
June 27, 2019
Will Capitalize on Rapid Internationalization of Clinical Trials Between the US and China
Pfizer to Acquire Array BioPharma for $11.4B contractpharma
June 18, 2019
Expands innovative biopharma business with multiple targeted investigational cancer therapies and adds a large portfolio of royalty-generating medicines.
Eurofins BioPharma Product Testing europeanpharmaceuticalreview
June 17, 2019
Eurofins BioPharma Product Testing.
RedHill Biopharma Submits New Drug Application for Talicia for H. pylori Infection drugs
May 17, 2019
RedHill Biopharma Submits New Drug Application for Talicia for H. pylori Infection.
Sekisui Invests $1.9M in Microbial Biopharma CDMO Business contractpharma
May 17, 2019
New BioProcess Innovation Center in UK will be operational by the end of 2019.
Clinical Catch-up from Last Week: May 5-10 biospace
May 13, 2019
Almost every week, biopharma companies release results from ongoing clinical trials. Here’s a roundup of some of the top clinical trial news from the previous week.
RedHill Biopharma enrols last patient in Phase II irritable bowel syndrome trial europeanpharmaceuticalreview
May 07, 2019
RedHill Biopharma has enrolled the last patient in the Phase II study with Bekinda for the treatment of diarrhoea-predominant irritable bowel syndrome…

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page